相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer
Jun-Nan Guo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)
Role of inhibitory B cell co-receptors in B cell self-tolerance to non-protein antigens*
Takeshi Tsubata
IMMUNOLOGICAL REVIEWS (2022)
Conjugate of ibrutinib with a TLR7 agonist suppresses melanoma progression and enhances antitumor immunity
Sumei Ren et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma
Yucang Shi et al.
PEERJ (2022)
Shared Gene Expression and Immune Pathway Changes Associated with Progression from Nevi to Melanoma
Elizabeth S. Borden et al.
CANCERS (2022)
NLRC3 High Expression Represents a Novel Predictor for Positive Overall Survival Correlated With CCL5 and CXCL9 in HCC Patients
Chengpan Wang et al.
FRONTIERS IN ONCOLOGY (2022)
Chemical reagents modulate nucleic acid-activated toll-like receptors
Xiao Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma
Changjiang Liu et al.
BMC MEDICAL GENOMICS (2022)
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Adel Naimi et al.
CELL COMMUNICATION AND SIGNALING (2022)
JAK-STAT core cancer pathway: An integrative cancer interactome analysis
Fettah Erdogan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)
Self-degradable poly(β-amino ester)s promote endosomal escape of antigen and agonist
Hong Liu et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers
Frank J. Lowery et al.
SCIENCE (2022)
Triplet Therapy in Melanoma - Combined BRAF/MEK Inhibitors and Anti-PD-(L)1 Antibodies
Julia R. Dixon-Douglas et al.
CURRENT ONCOLOGY REPORTS (2022)
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients
Maria Luigia Carbone et al.
SCIENTIFIC REPORTS (2022)
JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Bilal Rah et al.
FRONTIERS IN PHARMACOLOGY (2022)
Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer
Jinhui Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Neoadjuvant therapy for melanoma: rationale for neoadjuvant therapy and pivotal clinical trials
Russell G. Witt et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)
Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer
Shiyuan Wang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes
Xinyu Gu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients
Pier Francesco Ferrucci et al.
CURRENT ONCOLOGY REPORTS (2021)
Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation
Yong Gao et al.
BIOENGINEERED (2021)
Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma
Hao Yuan et al.
FRONTIERS IN IMMUNOLOGY (2021)
Development and Validation of a Combined Glycolysis and Immune Prognostic Model for Melanoma
Yang Yang et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
Mariana Matias et al.
CELLS (2021)
Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
Yan Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
Weihao Lin et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Memory-like Differentiation Enhances NK Cell Responses to Melanoma
Nancy D. Marin et al.
CLINICAL CANCER RESEARCH (2021)
Concomitant Antihyperalgesic and Antitumor Effects of Gabapentin in a Murine Cancer Pain Model
Beatriz Elena Brito et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prognostic signature and immune efficacy of m1A-, m5C- and m6A-related regulators in cutaneous melanoma
Xian rui Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Prognostic Value and Immunological Characteristics of a Novel RNA Binding Protein Signature in Cutaneous Melanoma
Jun Tian et al.
FRONTIERS IN GENETICS (2021)
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Development of a novel immune-related lncRNA signature as a prognostic classifier for endometrial carcinoma
Jinhui Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Melanoma pathology reporting and staging
Richard A. Scolyer et al.
MODERN PATHOLOGY (2020)
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Xu Lei et al.
CANCER LETTERS (2020)
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma
Lauren E. Haydu et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma
Maolang Tian et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma
Yu Liu et al.
BIOMED RESEARCH INTERNATIONAL (2020)
p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy
Chunwan Lu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
Furong Zeng et al.
FRONTIERS IN ONCOLOGY (2020)
Characterization of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma to Aid Immunotherapy
Xinhai Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
FCGR1A Serves as a Novel Biomarker and Correlates With Immune Infiltration in Four Cancer Types
Ji-li Xu et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Common Nevus and Skin Cutaneous Melanoma: Prognostic Genes Identified by Gene Co-Expression Network Analysis
Lingge Yang et al.
GENES (2019)
The Immunology of Macrophage Activation Syndrome
Courtney B. Crayne et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cancer Inflammation and Cytokines
Maria Rosaria Galdiero et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients
Michael Constantin Kirchberger et al.
EUROPEAN JOURNAL OF CANCER (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
The global burden of melanoma: results from the Global Burden of Disease Study 2015
C. Karimkhani et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Excision Margins for Melanoma In Situ on the Head and Neck
Sarah Felton et al.
DERMATOLOGIC SURGERY (2016)
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H. Raza Ali et al.
PLOS MEDICINE (2016)
Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma
Hiroyuki Inoue et al.
ONCOIMMUNOLOGY (2016)
NRGsuite: a PyMOL plugin to perform docking simulations in real time using FlexAID
Francis Gaudreault et al.
BIOINFORMATICS (2015)
SnapShot: T Cell Exhaustion
Kristen E. Pauken et al.
CELL (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
Mihaela Angelova et al.
GENOME BIOLOGY (2015)
Excision of fascia in melanoma thicker than 2 mm: no evidence for improved clinical outcome
R. E. Hunger et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Metabolic Effects of Acute Thiamine Depletion Are Reversed by Rapamycin in Breast and Leukemia Cells
Shuqian Liu et al.
PLOS ONE (2014)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study
W. Patricia Bandettini et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2012)
Immunologic considerations for generating memory CD8 T cells through vaccination
Noah S. Butler et al.
CELLULAR MICROBIOLOGY (2011)
Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: A review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer
Debora Landi et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2011)
Sparse kernel learning with LASSO and Bayesian inference algorithm
Junbin Gao et al.
NEURAL NETWORKS (2010)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Development of IFN-γ resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells
M. Fojtova et al.
BRITISH JOURNAL OF CANCER (2007)
Innovation - The Connectivity Map: a new tool for biomedical research
Justin Lamb
NATURE REVIEWS CANCER (2007)